Obesity management continues to face a critical barrier: adherence. Traditional land-based exercise models often fail individuals living with obesity due to joint pain, mobility limitations, and psychological barriers such as fear, discomfort, and perceived failure. As a result, [....] » Read More
Background and Rationale: Weight bias, the tendency to hold negative attitudes toward individuals based on body weight, is well-documented in the general population. Less openly examined is its presence within healthcare itself, including among the obesity medicine specialists ch [....] » Read More
Obesity is associated with a substantially increased risk of cardiovascular disease, including atrial fibrillation, heart failure, hypertension, sleep-disordered, and other sudden cardiac events. Wearable technologies, including smartwatches and wearable sensors, offer the possib [....] » Read More
The majority of people with Eating Disorders (ED) are of higher-weight yet EDs are minimized, underreported and often go untreated in these individuals. These individuals are half as likely to receive a clinical diagnosis of an eating disorder from a health care practitioner as t [....] » Read More
Background: Obesity is frequently approached through outdated weight-centric metrics and late-stage disease markers, often overlooking early metabolic dysfunction and the physiologic drivers of appetite regulation. While pharmacologic therapies have expanded treatment option [....] » Read More
Osteoarthritis (OA) is the most common form of arthritis in the United States, affecting approximately 24?% of adults. This review aims to summarize racial and ethnic disparities in OA prevalence, presentation, disability, diagnosis, and management among different groups in the U [....] » Read More
Background: Glucagon-like peptide-1 (GLP-1) receptor agonists can produce rapid weight loss, but this loss is frequently accompanied by disproportionate lean mass loss, especially during the early phase of GLP-1 treatment. Physical activity, particularly resistance training, is t [....] » Read More
Obesity, food addiction, and eating disorders are often approached as problems of behaviour, compliance, and personal responsibility. But what if part of the system designed to treat them is quietly reinforcing them? This talk challenges the prevailing narrative that patients sim [....] » Read More
Obesity and metabolic dysfunction-associated steatotic liver disease (MASLD), including metabolic dysfunction-associated steatohepatitis (MASH), are tightly linked disorders that should be approached as part of a unified cardiometabolic disease spectrum rather than as isolated he [....] » Read More
In today’s world, we are all impacted by how policies affect our nutritional status in terms of food development, processing, lifestyle choices, environment, and genetics. Exploration of EBP resources will help to serve as a framework for discussion for future practice mana [....] » Read More
This presentation explores obesity through the lens of social determinants of health, emphasizing how social, economic, and environmental factors drive unequal obesity risk and outcomes across populations. Obesity is not solely the result of individual behavior or biological pred [....] » Read More
In Portugal, the prevalence of pre-obesity is 34.8% and obesity is 22.3% (National Food and Physical Activity Survey, 2017). This prevalence is higher in the female population (24.3% vs. 20.1%). In the Algarve Region, the weighted prevalence of obesity is 30.4%. Around 322 millio [....] » Read More
Background: According to the World Health Organisation (WHO), more than 43% of adults are overweight, and the obesity rate is increasing quickly in the high-, low- and middle-income countries. Recently obesity is a chronic disease with a multifactorial etiology including genetics [....] » Read More
BACKGROUND: Obesity is a complex, multifactorial metabolic disorder characterised by excessive adipose tissue accumulation and chronic low-grade systemic inflammation. Once regarded solely as an energy reservoir, adipose tissue is now recognised as a dynamic endocrine organ that [....] » Read More
Obesity prevalence increases with age and is further exacerbated by consumption of a Western-style diet (WSD), which is characterized by high fat, refined sugars, processed foods, and low dietary fiber. Consistent with this, our studies show that adult/middle-aged mice develop ma [....] » Read More
Obesity is a complex chronic disease that exerts profound and interconnected effects on cardiovascular, kidney, and metabolic health. Yet most global care models continue to prioritize weight change alone while overlooking the multisystem nature of obesity-related organ dysfuncti [....] » Read More
Objective: Prediabetes with obesity is a high-risk phenotype for progression to type 2 diabetes. Continuous glucose monitoring (CGM) may strengthen lifestyle intervention through real-time feedback, and intensive coaching may amplify behaviour change, yet comparative data in this [....] » Read More
Introduction: Tibial plateau fractures (TPF) are high-energy fractures that often require surgery for proper healing. Literature identifies high body mass index (BMI) as a risk factor for poor surgical outcomes. This study aims to better understand how BMI affects outcomes after [....] » Read More
Title : Adaptability of whole room indirect calorimetry for mainstream health and wellness
Russell Rising, D & S Consulting Services Inc, United States
History of indirect calorimetry: Until recently clinical Energy Expenditure (EE) measurements consisted of Resting Metabolic Rate (RMR) or Exercise Energetics (EXEE) obtained by Metabolic Carts (MC). The first MC available was the Beckman MMC Horizon System (1975-1984). Shortly t [....] » Read More
Title : Challenges of obesity in the geriatric population
Hassan Massoud Heshmati, Endocrinology Metabolism Consulting, LLC, Hassan Heshmati and Valerie Shaw Endocrine Research, United States
Obesity is a major health problem worldwide. Over 1 billion adults around the globe have obesity. The global epidemic of obesity mainly results from a combination of genetic susceptibility, increased availability of high-energy foods, increased exposure to environmental obesogens [....] » Read More
Title : The blueprint of belonging: Aligning clinical intervention and fitness strategy to drive sustainable transformation, function, and well-being
Bob Esquerre, Esquerre Fitness Group International, United States
Join Bob as he returns to the WOC for the 3 rd time, bringing energy and insight to the evolving conversation on transforming health outcomes. He’ll continue to review how aligning clinical care and fitness coaching can move individuals from treatment to true transformation [....] » Read More
Title : VAMP, the inner work: A new pathway to sustainable weight loss
Michelle Petties, Brand New Now Press, United States
For decades, obesity treatment has focused primarily on the body—calories, compliance, medications, and surgical interventions—often overlooking the emotional, psychological, and trauma-based drivers that shape eating behaviors and long-term outcomes. This keynote pre [....] » Read More
Title : Redefining the metabolism of weight loss: Exercise signal and material nutrition
Auston Cherbonneaux, Freelance, United States
Calories in, calories out: that is what healthcare professionals are taught globally. A simplified model of metabolism, of our energy in the body, and the model we use to target fat-loss in the mission to conquer obesity. Despite this model's best efforts, it has not been abl [....] » Read More
Title : Adolescent weight loss medications and surgery
Asef Mahmud, AdventHealth, United States
The treatment of pediatric obesity is an urgent clinical priority because it prevents long-term health complications such as atherosclerosis, type 2 diabetes, high blood pressure, and various cancers that contribute to premature mortality and increased hospitalization. While life [....] » Read More
Title : The weight we carry: Obesity bias stigma workplace mental health
Kia Mitchell, International Women's Obesity Network, United States
Obesity is a chronic disease, but for millions of working adults its heaviest burden is carried not in the exam room but in the workplace. This session examines the psychological toll of workplace weight stigma through three converging vantage points: The patient, her treating ob [....] » Read More
Title : IAP: A predictor biomarker of obesity
Madhu S Malo, Stapgen LLC, United States
Background: Obesity is a chronic metabolic disease defined by the World Health Organization as excessive fat accumulation risking health, typically diagnosed by a BMI ≥ 30 kg/m2. Globally, it affects over 1 billion people and costs the global economy roughly $2.2 trillion annu [....] » Read More
Title : Patient reported outcomes of GLP 1/GIP agonist use for lipedema: Results from a survey based study
Jesse Cochrane, Lipedema Foundation, United States
Lipedema is a chronic condition characterized by disproportionate fat accumulation, inflammation, and pain, predominantly affecting women. Traditional treatments focus on symptom management, but emerging therapies, such as GLP-1/GIP receptor agonists like semaglutide and tirzepat [....] » Read More
Title : Epidemiological and diagnostic characteristics of children followed for overweight and obesity at the Albert Royer National Children’s Hospital Center in Senegal
Aminata Mbaye, UCAD, Senegal
The WHO defines obesity as an abnormal or excessive accumulation of body fat that may impair health. Obesity should be suspected when weight increases more rapidly than height; weight-for-height charts are the clinician’s primary tool. The WHO defines overweight as a BMI ab [....] » Read More